Model Checkpoint Epoch: 2.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity. Measurement of BF% may be a useful tool for identifying infants at risk of undernutrition who may benefit from early nutritional intervention. Future studies should investigate whether measuring BF% is cost effective and more practical for use in clinical settings. Further work is needed to determine how BF% can best be used as a screening tool for undernutrition in neonates. This could involve assessing its sensitivity, specificity, positive predictive value and negative predictive value, as well as investigating its relationship to other measures of undernutrition, such as birth weight percentiles. Measuring BF% may help identify undernourished neonates and prevent long-term adverse health consequences. In addition, it could help reduce hospital readmission rates and costs. Finally, BF% has the potential to become a standardised outcome measure for nutrition research in neonates. It is easy to measure, reproducible and correlated with other indices of undernutrition. In future, BF% could form part of routine clinical practice and be used as an outcome measure in randomised controlled trials. However, further work is required before it can be recommended for widespread use.
2016 by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.4
Reasoning:
The response correctly notes that low BF% is associated with increased neonatal morbidity and that further study is needed, but it fails to directly state the key finding from the study — that BF% is more closely associated with identifying neonates at risk than birth weight percentiles and can identify appropriately grown yet undernourished infants while excluding small but not-at-risk infants. It also makes overstated or unsupported claims (for example, calling BF% "easy to measure" and asserting likely reductions in readmissions and costs) without evidence. Overall the answer is cautious and partly accurate but omits the primary comparative conclusion and includes speculative or incorrect practical claims.

conciseness: 0.3
Reasoning:
The assistant's reply is verbose and indirect. It repeats that low BF% is associated with morbidity and calls for more research, but it does not clearly answer whether BF% is superior to birth weight percentiles; it adds extraneous future-research and practicality claims (and an odd citation line) that reduce conciseness and focus. Overall it fails to give a concise, direct comparison as asked.

relevance: 0.4
Reasoning:
The assistant's reply is only partly relevant. It correctly notes that low BF% is associated with increased neonatal morbidity and suggests BF% could help identify undernourished infants, but it fails to directly answer whether BF% is better than birth weight percentiles (it never states or cites the study's comparative finding that BF% was more closely associated with morbidity or provides the odds ratios). It also makes an unsupported claim that BF% is "easy to measure" despite the study using specialized air displacement plethysmography, and it omits key study results and direct comparison to birth weight percentiles.

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it states that low BF% is associated with neonatal morbidity, outlines potential clinical value, and recommends further research. However it does not directly answer whether BF% is better than birth weight percentiles (it avoids a clear comparative conclusion despite data supporting a stronger association), repeats themes, makes a few unsupported or contradictory claims (e.g., calling BF% “easy to measure” while also saying more work is needed before clinical use), and includes an extraneous footer. Overall, the answer is understandable but incomplete and somewhat inconsistent.

helpfulness: 0.5
Reasoning:
The assistant's reply correctly notes that low BF% is associated with higher neonatal morbidity and that BF% could help identify at-risk infants and guide further research. However, it fails to directly answer the question using the study's comparative results (which show BF% had a stronger association with morbidity than birth weight percentiles), and it makes some unsupported or misleading claims (for example, calling BF% "easy to measure" without mentioning that accurate BF% measurement (e.g., air displacement plethysmography) is not routinely available in many clinical settings). The reply is also vague and repetitive about future research needs instead of succinctly comparing the two measures or citing the study's effect sizes and implications for practice.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The endovascular revascularization is the first line of treatment for the ischemic Charcot neuroarthropathy. The surgical debridement and orthopedic correction should be considered as complementary therapy only if the infection cannot be controlled or if there are severe deformities. We have found that this treatment approach allows good limb salvage rate and short time to heal. These results could be useful for other centers dealing with similar cases. The aim of this study was to show that it is possible to treat patients affected by ischemic Charcot neuroarthropathy with a different approach from the classical one, allowing a better limb salvage rate and shorter healing times. It is important to remember that the outcome of these patients depends on a multidisciplinary team work, involving vascular surgeons, interventional radiologists, orthopedics and podiatrists. This multidisciplinary team must share the same goals, such as saving the limb, avoiding major amputations and reducing the risk of infection. It is also important to remember that the best management strategy for ischemic Charcot neuroarthropathy will depend on several factors, including the severity of the lesion, the level of the lesion, the patient's comorbidities, the presence of ulceration and the patient's functional status.
[/INST]
Endovascular revascularization seems to be the first choice of treatment for the ischemic Charcot neuroarthropathy. However, the surgical debridement and orthopedic correction should be considered as complementary therapy only if the infection cannot be controlled or if there are severe deformities. We believe that this treatment approach allows good limb salvage rate and short time to heal. Finally, we suggest that the best management strategy for ischemic Charcot neuroarthropathy will depend on several factors, including the severity of the lesion, the level of the lesion, the patient's comorbidities, the presence of ulceration and the patient's functional status. This multidisciplinary team must share the same goals, such as saving the limb, avoiding major amputations and reducing the risk of infection.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The response correctly emphasizes that revascularization is essential and that multidisciplinary care (vascular/interventional, orthopedic, podiatry) is important for ischemic Charcot foot, which matches the ground truth that revascularization supports surgical/orthopedic treatment and aids limb salvage. However, it overstates or misrepresents some points: calling endovascular revascularization unequivocally "first line" and presenting surgical debridement/orthopedic correction as merely “complementary only if infection cannot be controlled or if there are severe deformities” contradicts the study’s approach (where revascularization was followed by planned surgical and orthopedic interventions) and overgeneralizes clinical decision-making. The claim of a “short time to heal” is also misleading given the reported mean healing time (~197 days). The answer is repetitive and lacks nuance about when and how surgical/orthopedic procedures are integrated with revascularization.

conciseness: 0.3
Reasoning:
The response answers the question but is repetitive and wordy. It repeats the same conclusions twice, adds several general statements that don't add new information, and could be condensed into a single clear recommendation (revascularization plus multidisciplinary care supporting surgical/orthopedic treatment). Therefore it is not concise.

relevance: 0.8
Reasoning:
The assistant's reply is generally relevant: it directly answers whether ischemic Charcot foot is managed differently by stating that endovascular revascularization is central and that surgical/orthopedic measures are adjunctive, which reflects the study context (patients underwent revascularization followed by surgical and orthopedic treatment with high limb-salvage). It correctly emphasizes a multidisciplinary approach and patient-dependent factors. Minor issues: it omits the study's numeric outcomes (90% limb salvage, ~197 days healing) and slightly overstates that surgical/orthopedic care is only for uncontrolled infection or severe deformity, whereas the context describes these interventions as part of the combined treatment pathway. Overall the response is faithful to the context and relevant to the question.

coherence: 0.6
Reasoning:
The assistant's reply is generally coherent and organized: it states a treatment approach (endovascular revascularization followed by selective surgical/orthopedic procedures) and emphasizes multidisciplinary care and patient-specific factors. However, it is repetitive, lacks a direct, explicit answer to the user's question about whether ischemic Charcot foot is a different disease with different treatment (it implies difference but doesn't clearly compare ischemic vs non-ischemic Charcot or spell out how management differs), and overstates "first-line" without nuance. Overall clarity and structure are acceptable but could be improved by a succinct direct answer, less repetition, and a clearer comparison.

helpfulness: 0.6
Reasoning:
The assistant’s answer is broadly aligned with the ground truth (it emphasizes the importance of revascularization to enable limb- and foot-salvage and the need for multidisciplinary care), so it is helpful in conveying the main clinical message. However, it overstates and simplifies some points (calling endovascular revascularization unequivocally “first line” without acknowledging patient selection, alternative revascularization strategies, timing, or the small retrospective sample), repeats itself, and omits important specifics from the presented data (the 90% limb salvage rate and mean healing time ~197 days) and limitations (small n, retrospective design). It also frames surgical/orthopedic treatment as only for uncontrolled infection or severe deformity, which is an oversimplification of clinical practice where combined planning and individualized timing are common.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although the prognosis of patients with endometrial cancer with suspected cervical involvement may be improved by RH, it seems to be unnecessary in this group of patients. Thus, SH should be considered as an alternative option when appropriate. Further studies are needed to clarify the optimal surgical strategy for these patients. Gynecol Oncol 2016;143:281-287. © 2016 Ferrari et al. This work is licensed under the Creative Commons Attribution-NonCommercial License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc/4.0/. For commercial use or other questions, contact [email protected].

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.4
Reasoning:
The assistant's reply is partially correct but flawed. It correctly suggests that radical hysterectomy (RH) appears unnecessary and that simple hysterectomy (SH) can be considered, and it correctly calls for further study. However the opening sentence is contradictory and misleading ("Although the prognosis ... may be improved by RH, it seems to be unnecessary") — the GOTIC-005 data did not show a survival benefit for RH and actually identified no effect of hysterectomy type on prognosis. The response also omits key findings that RH was associated with more perioperative and late adverse events (longer operative time, more transfusions, higher urinary dysfunction). It includes irrelevant licensing/contact details. Overall the answer is incomplete and contains an inaccurate/ambiguous statement that could mislead readers.

conciseness: 0.6
Reasoning:
The response is brief and gives a clear take-home (that simple hysterectomy can be considered), but it contains a contradictory opening statement suggesting RH "may" improve prognosis (which conflicts with the study's finding of no survival benefit) and includes unnecessary licensing/contact text that reduces conciseness and focus.

relevance: 0.2
Reasoning:
Explanation: The response is only partially relevant and contains factual inaccuracies. The study context reports no survival benefit from radical hysterectomy (RH), that type of hysterectomy was not an independent prognostic factor, and that RH had more perioperative and late adverse events — but the assistant's answer starts by suggesting RH "may" improve prognosis, then contradictorily says RH is unnecessary. It does not quote or accurately mirror the provided findings, and it adds an unrelated citation/license block. Overall it fails to faithfully represent the study conclusions.

coherence: 0.3
Reasoning:
The response is poorly coherent. It contains a direct contradiction ("Although the prognosis ... may be improved by RH" vs. "it seems to be unnecessary"), fails to mention key study findings (that RH had more perioperative and late adverse events and showed no survival benefit), and includes extraneous licensing/citation text that doesn't clarify the conclusion. The concluding recommendation (consider SH) is consistent with the study result but is not supported clearly by the answer's reasoning.

helpfulness: 0.3
Reasoning:
The assistant's reply is brief but flawed. It begins with a contradictory statement ("prognosis ... may be improved by RH") that is not supported by the GOTIC-005 results, then concludes RH "seems to be unnecessary" and that SH can be considered, which only partially matches the study. The response omits key study findings (type of hysterectomy was not an independent prognostic factor for OS/PFS/local recurrence; RH had higher perioperative and late adverse events; no survival benefit from RH) and provides extraneous/licensing/contact text unrelated to the clinical answer. Overall the reply is misleading and incomplete.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Pancreatic fistula, multivisceral resections, prolonged initial hospital stays, and ICU admissions are independent risk factors for readmissions after PD. Improved patient selection and better preoperative optimization may help reduce readmissions. The development of new technologies, such as robotics and laparoscopy, should be evaluated based on their ability to decrease readmissions. Finally, further evaluation of preoperative risk stratification systems will help us identify high-risk patients who would benefit from enhanced surveillance. Reduction of readmissions after PD is critical for improving patient outcomes and reducing health-care expenses. Further studies are needed to develop a standardized approach to improve readmission rates and patient outcomes after PD. © 2014 Journal of Gastrointestinal Surgery. Published by Wiley Periodicals, Inc.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The assistant correctly identifies the independent risk factors from the study (pancreatic fistula, multivisceral/complex resections, prolonged initial stay, ICU admission). However it omits the key finding that half of readmissions occur early (≤7 days) and that efforts should specifically target preventing these early readmissions and their distinct causes. The reply also adds speculative recommendations (e.g., robotics/laparoscopy) not supported by the study data and includes an irrelevant copyright line. Overall partly correct but incomplete and with extraneous content.

conciseness: 0.5
Reasoning:
The assistant succinctly lists the independently associated risk factors (pancreatic fistula, multivisceral resection, prolonged initial stay, ICU admission), which directly answers part of the question. However it omits the key finding that half of readmissions occur within 7 days and that efforts should target preventing early readmissions; it also adds speculative recommendations (robotics/laparoscopy) not supported by the provided data and includes an irrelevant copyright line. Overall moderately concise but misses a critical conclusion and contains extraneous material. 


relevance: 0.6
Reasoning:
The assistant correctly identifies several independent risk factors reported in the context (pancreatic fistula, multivisceral/complex resection, prolonged initial hospital stay, and ICU admission), so its summary of predictors is relevant to the question. However, it omits the context's key recommendation to focus on preventing early readmissions (about half occur ≤7 days), and it proposes interventions (robotics/laparoscopy) and general strategies that are not supported or discussed in the provided text. The reply also adds an irrelevant copyright line. Overall the response is partially relevant but incomplete and includes unsupported suggestions.

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it correctly lists several independent risk factors for readmission after PD (pancreatic fistula, multivisceral resection, prolonged stay, ICU admission) and proposes broad prevention strategies (better selection, optimization, risk stratification, surveillance). However it omits a key finding from the study — that half of readmissions occur within 7 days and that prevention efforts should particularly target early readmissions — and it offers only vague interventions (and an unsubstantiated suggestion about robotics/laparoscopy) rather than specific, evidence-based measures tailored to early versus late readmissions. The inclusion of a copyright line is irrelevant to the answer.

helpfulness: 0.6
Reasoning:
The response correctly lists several independent risk factors identified in the study (pancreatic fistula, multivisceral resection, prolonged initial stay, ICU admission) and gives reasonable general recommendations (improved patient selection, preoperative optimization, risk stratification, targeted surveillance). However, it is fairly generic, omits an important study conclusion — that half of readmissions occur very early (≤7 days) and that prevention efforts should particularly target early-readmission causes (ileus, delayed gastric emptying, pneumonia) — and does not discuss differing etiologies or specific measures to prevent early versus late readmissions. It also includes an extraneous copyright line. Overall the answer is partially helpful but lacks the key emphasis and actionable detail present in the ground truth.

================================================================================
Average correctness Score: 0.475
Average conciseness Score: 0.375
Average relevance Score: 0.485
Average coherence Score: 0.51
Average helpfulness Score: 0.465
